Skip to content
Screener

Discontinued — last reported Q4 '23

Free cash flow at other companies

Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
$385.77M-4.4%
Bit Digital logo
Bit DigitalBTBT
-$127.68M-98.0%
DigitalBridge Group logo
DigitalBridge GroupDBRG
-$40.1M-180%
StoneX Group Inc. logo
StoneX Group Inc.SNEX
$2.78B+1,736%
TEC
Bio-Techne Corp.TECH
$86.94M-6.8%
Boston Scientific logo
Boston ScientificBSX
$171M-51.7%

Other financials

Income statement

See full
Revenue$146.0K
Gross profit$12.0K-88.9%
Operating income-$15.2M+25.6%
Net income-$14.6M+28.6%
EPS (diluted)-$0.08+89.2%

Balance sheet

See full
Cash & equivalents$5.6M+98.8%
Total debt$800.0K+5,233%
Total equity$145.6M+4,126%
Total assets$159.6M+45.4%

Cash flow

See full
Operating cash flow-$11.7M-819%
CapEx$4.0K-93.1%

Valuation

See full
Market cap$90.06M-46.6%
Enterprise value$85.26M-48.6%
P/S523.6×-1,410×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio20.2×+20.2×

Where this comes from

Calculated from BioSig Technologies, Inc.’s reported figures.

The source filing: BioSig Technologies, Inc.’s 10-K, filed April 15, 2025. Open the filing →

Filed
Apr 15, 2025
Fiscal year
FY2024
Accession
0001641172-25-004816

FAQ

What is BioSig Technologies, Inc.'s free cash flow?
BioSig Technologies, Inc. (STEX) reported free cash flow of -$2.95M in Q4 2023.
How has BioSig Technologies, Inc.'s free cash flow changed year-over-year?
BioSig Technologies, Inc.'s free cash flow increased by 29.4% year-over-year, from -$4.17M to -$2.95M.
What is the long-term trend for BioSig Technologies, Inc.'s free cash flow?
Over 2 years (2021 to 2023), BioSig Technologies, Inc.'s free cash flow has grown at a -19.4% compound annual growth rate (CAGR), from -$26.94M to -$17.5M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about BioSig Technologies, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude